Cagrilintide is a synthetic peptide analog of amylin, a naturally occurring hormone co-secreted with insulin by pancreatic β-cells. It is currently under investigation for its role in appetite regulation and metabolic signaling.

As an amylin receptor agonist, Cagrilintide has been studied for its effects on gastric emptying, satiety signaling, and central pathways related to energy intake.

✔ Amylin Pathway Activation: Mimics endogenous amylin to engage satiety and appetite-related pathways.

✔ Metabolic Signaling: Explored for its role in glucose and energy regulation.

✔ Combination Therapy Potential: Studied in conjunction with GLP-1 receptor agonists in metabolic research.

Cagrilintide remains a focus of clinical and investigational interest for its novel mechanism and applications in metabolic and endocrine studies.

Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use without the guidance of a qualified healthcare professional.